A pivotal role for interleukin-27 in CD8+ T cell functions and generation of cytotoxic T lymphocytes

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Yoshimoto, Takayuki ^a   Morishima, Noriko ^a   Mizoguchi, Izuru ^a   Okumura, Masae ^a   Chiba, Yukino ^a   Xu, Mingli ^a   Shimizu, Motomu ^b   Matsui, Masanori ^c   Mizuguchi, Junichiro ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EOMESODERMIN; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 12; INTERLEUKIN 27; INTERLEUKIN 6; PERFORIN; STAT1 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR T BET; INTERLEUKIN 17;

ANTIGEN SPECIFICITY; ANTINEOPLASTIC ACTIVITY; CD8+ T LYMPHOCYTE; COLON CARCINOMA; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DRUG MECHANISM; HEAD AND NECK CARCINOMA; IMMUNE RESPONSE; LUNG CANCER; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MELANOMA; NEUROBLASTOMA; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TH1 CELL; UPREGULATION; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CYTOLOGY; HUMAN; IMMUNOLOGY; NEOPLASM;

ANIMALS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; NEOPLASMS; ORGAN SPECIFICITY; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 77952525594     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/605483     Document Type: Review

References (92)

1. Kaech S. M., Wherry E. J., Ahmed R., Effector and memory T-cell differentiation: implications for vaccine development Nature Reviews Immunology 2002 2 4 251 262
2. Szabo S. J., Kim S. T., Costa G. L., Zhang X., Fathman C. G., Glimcher L. H., A novel transcription factor, T-bet, directs Th1 lineage commitment Cell 2000 100 6 655 669
3. Szabo S. J., Sullivan B. M., Sternmann C., Satoskar A. R., Sleckman B. P., Glimcher L. H., Distinct effects of T-bet in Th1 lineage commitment and IFN-production in CD4 and CD8 T cells Science 2002 295 5553 338 342
4. Townsend M. J., Weinmann A. S., Matsuda J. L., T-bet regulates the terminal maturation and homeostasis of NK and V 14i NKT cells Immunity 2004 20 4 477 494
5. Sullivan B. M., Juedes A., Szabo S. J., Von Herrath M., Glimcher L. H., Antigen-driven effector CD8 T cell function regulated by T-bet Proceedings of the National Academy of Sciences of the United States of America 2003 100 26 15818 15823
6. Juedes A. E., Rodrigo E., Togher L., Glimcher L. H., Von Herrath M. G., T-bet controls autoaggressive CD8 lymphocyte responses in type 1 diabetes Journal of Experimental Medicine 2004 199 8 1153 1162
7. + T cell function by the transcription factor Eomesodermin Science 2003 302 5647 1041 1043
8. Russ A. P., Wattler S., Colledge W. H., Eomesodermin is required for mouse trophoblast development and mesoderm formation Nature 2000 404 6773 95 99
9. + T cells lacking T-bet and eomesodermin Science 2008 321 5887 408 411
10. + T cells Nature Immunology 2002 3 6 549 557
11. Lighvani A. A., Frucht D. M., Jankovic D., T-bet is rapidly induced by interferon-in lymphoid and myeloid cells Proceedings of the National Academy of Sciences of the United States of America 2001 98 26 15137 15142
12. Takeda A., Hamano S., Yamanaka A., Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of Stat1 during initial Th1 commitment Journal of Immunology 2003 170 10 4886 4890
13. + T cells Journal of Immunology 2004 173 6 3871 3877
14. + T cells through Stat1-dependent and-independent mechanisms Proceedings of the National Academy of Sciences of the United States of America 2003 100 25 15047 15052
15. + T cell generation with enhanced granzyme B expression by IL-27 Journal of Immunology 2005 175 3 1686 1693
16. Matsui M., Moriya O., Belladonna M. L., Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A 0201 transgenic mice Journal of Virology 2004 78 17 9093 9104
17. Hisada M., Kamiya S., Fujita K., Potent antitumor activity of interleukin-27 Cancer Research 2004 64 3 1152 1156
18. + T cells Journal of Immunology 2004 173 12 7170 7182
19. Shinozaki Y., Wang S., Miyazaki Y., Tumor-specific cytotoxic T cell generation and dendritic cell function are differentially regulated by interleukin 27 during development of anti-tumor immunity International Journal of Cancer 2009 124 6 1372 1378
20. Chiyo M., Shimozato O., Iizasa T., Fujisawa T., Tagawa M., Antitumor effects produced by transduction of dendritic cells-derived heterodimeric cytokine genes in murine colon carcinoma cells Anticancer Research 2004 24 6 3763 3767
21. Chiyo M., Shimozato O., Yu L., Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals International Journal of Cancer 2005 115 3 437 442
22. Trinchieri G., Interleukin-12 and the regulation of innate resistance and adaptive immunity Nature Reviews Immunology 2003 3 2 133 146
23. Kastelein R. A., Hunter C. A., Cua D. J., Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation Annual Review of Immunology 2007 25 221 242
24. Oppmann B., Lesley R., Blom B., Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12 Immunity 2000 13 5 715 725
25. Parham C., Chirica M., Timans J., A receptor for the heterodimeric cytokine IL-23 is composed of IL-12R 1 and a novel cytokine receptor subunit, IL-23R Journal of Immunology 2002 168 11 5699 5708
26. Yang X. O., Panopoulos A. D., Nurieva R., STAT3 regulates cytokine-mediated generation of inflammatory helper T cells Journal of Biological Chemistry 2007 282 13 9358 9363
27. + T cells Immunity 2002 16 6 779 790
28. Chen Q., Ghilardi N., Wang H., Development of Th1-type immune responses requires the type I cytokine receptor TCCR Nature 2000 407 6806 916 920
29. Sprecher C. A., Grant F. J., Baumgartner J. W., Cloning and characterization of a novel class I cytokine receptor Biochemical and Biophysical Research Communications 1998 246 1 82 90
30. Pflanz S., Hibbert L., Mattson J., WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27 Journal of Immunology 2004 172 4 2225 2231
31. Devergne O., Hummel M., Koeppen H., A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes Journal of Virology 1996 70 2 1143 1153
32. Devergne O., Birkenbach M., Kieff E., Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin Proceedings of the National Academy of Sciences of the United States of America 1997 94 22 12041 12046
33. Niedbala W., Wei X.-Q., Cai B., IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells European Journal of Immunology 2007 37 11 3021 3029
34. Collison L. W., Workman C. J., Kuo T. T., The inhibitory cytokine IL-35 contributes to regulatory T-cell function Nature 2007 450 7169 566 569
35. Owaki T., Asakawa M., Morishima N., STAT3 is indispensable to IL-27-mediated cell proliferation but not to IL-27-induced Th1 differentiation and suppression of proinflammatory cytokine production Journal of Immunology 2008 180 5 2903 2911
36. + T cells partially through STAT3-dependent mechanism Journal of Immunology 2006 177 8 5377 5385
37. Villarino A. V., Huang E., Hunter C. A., Understanding the pro-and anti-inflammatory properties of IL-27 Journal of Immunology 2004 173 2 715 720
38. Yoshida H., Hamano S., Senaldi G., WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection Immunity 2001 15 4 569 578
39. Owaki T., Asakawa M., Morishima N., A role for IL-27 in early regulation of Th1 differentiation Journal of Immunology 2005 175 4 2191 2200
40. Hibbert L., Pflanz S., De Waal Malefyt R., Kastelein R. A., IL-27 and IFN-signal via Stat1 and Stat3 and induce T-Bet and IL-12R 2 in naive T cells Journal of Interferon and Cytokine Research 2003 23 9 513 522
41. Owaki T., Asakawa M., Fukai F., Mizuguchi J., Yoshimoto T., IL-27 induces Th1 differentiation via p38 MAPK/T-bet-and intercellular adhesion molecule-1/LFA-1/ERK1/2-dependent pathways Journal of Immunology 2006 177 11 7579 7587
42. Yoshimoto T., Yoshimoto T., Yasuda K., Mizuguchi J., Nakanishi K., IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: a novel therapeutic way for Th2-mediated allergic inflammation Journal of Immunology 2007 179 7 4415 4423
43. Artis D., Johnson L. M., Joyce K., Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection Journal of Immunology 2004 172 8 4672 4675
44. Villarino A., Hibbert L., Lieberman L., The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection Immunity 2003 19 5 645 655
45. Stumhofer J. S., Laurence A., Wilson E. H., Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system Nature Immunology 2006 7 9 937 945
46. Hamano S., Himeno K., Miyazaki Y., WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production Immunity 2003 19 5 657 667
47. Batten M., Li J., Yi S., Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells Nature Immunology 2006 7 9 929 936
48. Fitzgerald D. C., Ciric B., Touil T., Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis Journal of Immunology 2007 179 5 3268 3275
49. Stumhofer J. S., Silver J. S., Laurence A., Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10 Nature Immunology 2007 8 12 1363 1371
50. Fitzgerald D. C., Zhang G.-X., El-Behi M., Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells Nature Immunology 2007 8 12 1372 1379
51. Batten M., Kljavin N. M., Li J., Walter M. J., De Sauvage F. J., Ghilardi N., Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells Journal of Immunology 2008 180 5 2752 2756
52. Awasthi A., Carrier Y., Peron J. P. S., A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells Nature Immunology 2007 8 12 1380 1389
53. Pot C., Jin H., Awasthi A., Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. Journal of Immunology 2009 183 2 797 801
54. Wong P., Pamer E. G., CD8 T cell responses to infectious pathogens Annual Review of Immunology 2003 21 29 70
55. Lechner F., Wong D. K. H., Dunbar P. R., Analysis of successful immune responses in persons infected with hepatitis C virus Journal of Experimental Medicine 2000 191 9 1499 1512
56. Gurunathan S., Klinman D. M., Seder R. A., DNA vaccines: immunology, application, and optimization Annual Review of Immunology 2000 18 927 974
57. Brunda M. J., Luistro L., Warrier R. R., Antitumor and antimetastatic activity of interleukin 12 against murine tumors Journal of Experimental Medicine 1993 178 4 1223 1230
58. Colombo M. P., Trinchieri G., Interleukin-12 in anti-tumor immunity and immunotherapy Cytokine and Growth Factor Reviews 2002 13 2 155 168
59. Marshall E., Cancer trial of interleukin-12 halted Science 1995 268 1555
60. Shimizu M., Shimamura M., Owaki T., Antiangiogenic and antitumor activities of IL-27 Journal of Immunology 2006 176 12 7317 7324
61. Oniki S., Nagai H., Horikawa T., Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma Cancer Research 2006 66 12 6395 6404
62. Yoshimoto T., Morishima N., Mizoguchi I., Antiproliferative activity of IL-27 on melanoma Journal of Immunology 2008 180 10 6527 6535
63. Matsui M., Kishida T., Nakano H., Lnterleukin-27 activates natural killer cells and suppresses NK-resistant head and neck squamous cell carcinoma through inducing antibody-dependent cellular cytotoxicity Cancer Research 2009 69 6 2523 2530
64. Ho M. Y., Leu S. J., Sun G. H., IL-27 directly restrains lung tumorigenicity by suppressing cyclooxygenase-2-mediated activities The Journal of Immunology 2009 183 10 6217 6226
65. Kaplan M. H., Sun Y.-L., Hoey T., Grusby M. J., Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice Nature 1996 382 6587 174 177
66. Thierfelder W. E., van Deursen J. M., Yamamoto K., Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells Nature 1996 382 6587 171 174
67. Car B. D., Eng V. M., Schnyder B., Role of interferon-in interleukin 12-induced pathology in mice American Journal of Pathology 1995 147 6 1693 1707
68. Car B. D., Eng V. M., Lipman J. M., Anderson T. D., The toxicology of interleukin-12: a review Toxicologic Pathology 1999 27 1 58 63
69. Ryffel B., Interleukin-12: role of interferon-in IL-12 adverse effects Clinical Immunology and Immunopathology 1997 83 1 18 20
70. Wang S., Miyazaki Y., Shinozaki Y., Yoshida H., Augmentation of antigen-presenting and Th1-promoting functions of dendritic cells by WSX-1(IL-27R) deficiency Journal of Immunology 2007 179 10 6421 6428
71. Bach E. A., Aguet M., Schreiber R. D., The IFN receptor: a paradigm for cytokine receptor signaling Annual Review of Immunology 1997 15 563 591
72. Stetson D. B., Mohrs M., Reinhardt R. L., Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function Journal of Experimental Medicine 2003 198 7 1069 1076
73. Mayer K. D., Mohrs K., Crowe S. R., The functional heterogeneity of type 1 effector T cells in response to infection is related to the potential for IFN-production Journal of Immunology 2005 174 12 7732 7739
74. Mayer K. D., Mohrs K., Reiley W., Cutting edge: T-bet and IL-27R are critical for in vivo IFN-production by CD8 T cells during infection Journal of Immunology 2008 180 2 693 697
75. + T cells to increase their abundance during virus infection Journal of Experimental Medicine 2005 201 7 1053 1059
76. Glimcher L. H., Townsend M. J., Sullivan B. M., Lord G. M., Recent developments in the transcriptional regulation of cytolytic effector cells Nature Reviews Immunology 2004 4 11 900 911
77. Alexander W. S., Hilton D. J., The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response Annual Review of Immunology 2004 22 503 529
78. Yoshimura A., Naka T., Kubo M., SOCS proteins, cytokine signalling and immune regulation Nature Reviews Immunology 2007 7 6 454 465
79. Croker B. A., Krebs D. L., Zhang J.-G., SOCS3 negatively regulates IL-6 signaling in vivo Nature Immunology 2003 4 6 540 545
80. Lang R., Pauleau A.-L., Parganas E., SOCS3 regulates the plasticity of gp130 signaling Nature Immunology 2003 4 6 546 550
81. Yasukawa H., Ohishi M., Mori H., IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages Nature Immunology 2003 4 6 551 556
82. Nicholson S. E., De Souza D., Fabri L. J., Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130 Proceedings of the National Academy of Sciences of the United States of America 2000 97 12 6493 6498
83. Owaki T., Asakawa M., Kamiya S., IL-27 suppresses CD28-medicated IL-2 production through suppressor of cytokine signaling 3 Journal of Immunology 2006 176 5 2773 2780
84. Villarino A. V., Stumhofer J. S., Saris C. J. M., Kastelein R. A., De Sauvage F. J., Hunter C. A., IL-27 limits IL-2 production during Th1 differentiation Journal of Immunology 2006 176 1 237 247
85. Villarino A. V., Tato C. M., Stumhofer J. S., Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals Journal of Experimental Medicine 2007 204 1 65 71
86. Chen Z., Laurence A., Kanno Y., Selective regulatory function of SOCS3 in the formation of IL-17-secreting T cells Proceedings of the National Academy of Sciences of the United States of America 2006 103 21 8137 8142
87. Kinjyo I., Inoue H., Hamano S., Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-1 Journal of Experimental Medicine 2006 203 4 1021 1031
88. Brender C., Tannahill G. M., Jenkins B. J., SOCS3 regulates CD8 T cell proliferation by inhibition of IL-6 and IL-27 Blood 2007 110 7 2528 2536
89. Banerjee A., Banks A. S., Nawijn M. C., Chen X. P., Rothman P. B., Cutting edge: suppressor of cytokine signaling 3 inhibits activation of NFATp Journal of Immunology 2002 168 9 4277 4281
90. Matsumoto A., Seki Y.-I., Watanabe R., A role of suppressor of cytokine signaling 3 (SOCS3/CIS3/SSI3) in CD28-mediated interleukin 2 production Journal of Experimental Medicine 2003 197 4 425 436
91. Takahashi Y., Carpino N., Cross J. C., Torres M., Parganas E., Ihle J. N., SOCS3: an essential regulator of LIF receptor signaling in trophoblast giant cell differentiation The EMBO Journal 2003 22 3 372 384
92. Jenkins B. J., Roberts A. W., Najdovska M., Grail D., Ernst M., The threshold of gp130-dependent STAT3 signaling is critical for normal regulation of hematopoiesis Blood 2005 105 9 3512 3520